CYP3A4 rs2242480C>T, SLC22A11 (OAT4) rs11231809T>A, TLR2 rs4696480T>A, and IL6 rs1800796C>G genetic polymorphisms are associated with the incidence of infections among patients undergoing cytotoxic chemotherapy. This evidence concerns the gene SLC22A11 and infection.